Solorank.ai
Login

Cached score snapshot

US.SYK · Stryker Corporation

110分制 53.9/110；5D動能v2 22/50；排序分 75.9/160 · Incomplete inputs

Back to ranking Open volume snapshot
Ranking score 75.9/160
Main score 53.9/110
5D momentum v2 22/50
Rank #84
Setup grade D 40.2

Score breakdown

避免

Medium twelvedata

Score and price trend

D 40.2 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 04-30 06-12 07-28 08-18 09-07 $272.65$333.22$393.78 Price Projection date
Historical projection
Model Median P25/P75 Win rate Down5 Actual / compare
Rolling DOE best · score 2.383 · anchors 120 -0.12% -1.86% / +2.00% 47.8% 5.2% Actual outcome pending · 0 / 3 bars observed
30D observation +5.22% -0.43% / +10.19% 73% 12.8% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 -0.23% -2.21% / +1.79% 45.6% 4.4% Actual outcome pending · 0 / 10 bars observed

Historical projection is based on archived similar setups. It is not a recommendation or guaranteed forecast.

2026-04-30 → 2026-09-07 · 120 archived points · 3 Improving turn signal · 8 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 75.9
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 53.9/110 (避免)
5D momentum v2 22/50 (中)
Score with momentum v2 75.9/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Incomplete score

此 snapshot 已計出評分，但以下輸入仍不完整；缺失維度以 0 分處理，請留意 audit 明细。

  • VIX_MISSING: VIX market context is required for market environment scoring

Market inputs

Bar count 60
ma20 323.1225
ma50 314.6064
close 336.74
prevClose 330.25
avgVolume20 2424077
volumeRatio 0.68
changePercent 1.97

Metrics snapshot

close 336.74
volume 1645135
changePercent 1.97

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 53.9/110
Main rating 避免
5D momentum v2 22/50
Score with momentum v2 75.9/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.5/5 · 良好
Dimension score 3.5/5
Dimension grade 良好

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.6
debtPoints 0.4
marginPoints 0.4
turnoverUsdM 553.9827
volumePoints 0.5
revenuePoints 0.4
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 12.4/20 · 一般
Dimension score 12.4/20
Dimension grade 一般

Sub-items

cmfPoints 1.6
mfiPoints 2.4
obvPoints 4
vwapPoints 2.4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.SYK
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 3.6/15 · 較差
Dimension score 3.6/15
Dimension grade 較差

Sub-items

vix

score 0

details

source twelvedata+fred
missing true
vixClose n/a

trend

score 0.8

details

qqq

ma20 710.49
ma50 717.6342
name QQQ
close 682.06
points 0.4

spy

ma20 746.6545
ma50 745.0022
name SPY
close 739.02
points 0.4
source twelvedata+fred
atrPct 3.0373
atrPoints 2
cciPoints 0.8
vixPoints 0
marketTrendPoints 0.8

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 6.5/10 · 一般
Dimension score 6.5/10
Dimension grade 一般

Sub-items

position

score 1.3

details

atrPct 3.0373
turnoverUsdM 553.9827
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.SYK
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 316.2842

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 6.1
take_profit_price 360.0596
target_multiplier 1.9
technical_strength 1.8
take_profit_percent 6.9
positionPoints 1.3
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.0747
diversificationPoints 2

技術信號 — 21.9/30 · 良好
Dimension score 21.9/30
Dimension grade 良好

Sub-items

bbPoints 3
adxPoints 3
sarPoints 3
vcpPoints 1.5
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 1.5
vcp_reason 跌縮量(近10日4日)；站上MA50；收盤突破20日高位；Ready=N；Confirm=Y

vcp_metrics

up_days 4
vol_ref 2600566.6667
down_days 5
vcp_ready false
above_ma50 true
avg_vol_10 2383730
avg_vol_20 2617210
avg_vol_30 2600566.6667
range_pct_10 0.088
range_pct_20 0.088
range_pct_30 0.1098
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok true
up_expand_days 1
breakout_20d_ok true
vol_ratio_10_30 0.9166
dist_to_20d_high -0.0018
down_shrink_days 4
breakout_level_20d 336.15
vcp_breakout_confirm true
contraction_ratio_10_30 0.8014
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.8
rsiKdjPoints 3.2
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 1
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 0.4

情緒分析 — 4/10 · 較差
Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 2
sentimentScoreRaw 0.6

sentimentData

raw {"id":141035262,"url":"https://finnhub.io/api/news?id=3647e16ddb54bcb74608f6e6fedc1a1a9698d86be7c61a3e3fdbb16221dff9ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"PAHC vs. SYK: Which Stock Is the Better Value Option?","category":"company","datetime":1785166802,"headline":"PAHC vs. SYK: Which Stock Is the Better Value Option?"}, {"id":141033951,"url":"https://finnhub.io/api/news?id=fcecda06d78a64160b71a7c83b72c3f8c835a6e8f5af835e1d1b85f851c8ee0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.","category":"company","datetime":1785158111,"headline":"Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS"}, {"id":140944900,"url":"https://finnhub.io/api/news?id=e77d76f3434f17b44a7271a4b4178cd3a084000ccbc8170e1df151c1706c49f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while market based multiples look closer to fair. Over five years, Stryker has returned 28.3%, which points to steady but not dramatic long term gains for shareholders. New products such as the Mako RPS handheld robotic system can support expectations for future cash...","category":"company","datetime":1784394439,"headline":"Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings"}, {"id":140940547,"url":"https://finnhub.io/api/news?id=c2585392dea75a3bc277f15d8952bba6cd6eb3516ae5a01c7312595cfaa19a1b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move extends the Mako ecosystem beyond robotic-arm systems into handheld robotics, potentially broadening adoption by matching robotic precision with familiar surgical workflows. Next, we’ll explore how expanding the...","category":"company","datetime":1784344509,"headline":"Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK)"}, {"id":140940111,"url":"https://finnhub.io/api/news?id=ebe2202ade933d00e63044350229e08b82e7db86b01a7ae08cdabb4732e1e7be","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements that extends its established Mako orthopaedic robotics portfolio. See our latest analysis for Stryker. The U.S. launch of Mako RPS comes as Stryker’s share price sits at US$319.87 after a recent pullback, with a 30 day share price return of 6.22% but a 1 year total shareholder return that declined 17.02%. This suggests enthusiasm around its...","category":"company","datetime":1784336914,"headline":"Stryker (SYK) Launches Mako RPS As Its Valuation Story Comes Into Focus"}, {"id":140857121,"url":"https://finnhub.io/api/news?id=d5da76e3d463a1659eb229b2fb369439662f69c42499cdfd038f9ac17e2e5543","image":"","source":"Fintel","related":"SYK","summary":"","category":"company","datetime":1783645922,"headline":"BMO Capital Initiates Coverage of Stryker (SYK) with Outperform Recommendation"}, {"id":140854814,"url":"https://finnhub.io/api/news?id=11054f196b0e32b5c2809d2d7a6f50cab93df0a950a9feb5bb887db5b936089a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (NYSE:SYK) has been removed from multiple Russell growth indices following the latest rebalancing. The company recently faced a cyberattack that disrupted certain operations. Despite the index exits and cyber incident, some active investors have shown renewed interest in the stock. These shifts may influence trading volumes and how both passive and active funds approach NYSE:SYK. Stryker is a large medical technology company focused on surgical equipment, orthopedics and related...","category":"company","datetime":1783624224,"headline":"Stryker (SYK) Stock Loses Russell Growth Slots As Active Investors Step In"}, {"id":140853728,"url":"https://finnhub.io/api/news?id=afb7bb7649d73fdfc58e4a1c34838d3a219a2539822045c42434a80349996b22","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here. The global equity market continued its rally in May, driven by accelerating AI infrastructure spending and a stronger-than-expected earnings season. The Fund (Platform Class) returned 2.1%, underperforming the MSCI World ex-Australia Index’s 4.5% […]","category":"company","datetime":1783613050,"headline":"Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance"}
raw_source {"id":141035129,"url":"https://finnhub.io/api/news?id=c92ef4a473af545abf93085c0feb833d345113b7ee6e12a65912c65c41f0d0ff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.","category":"company","datetime":1785167220,"headline":"J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?"}, {"id":141035262,"url":"https://finnhub.io/api/news?id=3647e16ddb54bcb74608f6e6fedc1a1a9698d86be7c61a3e3fdbb16221dff9ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"PAHC vs. SYK: Which Stock Is the Better Value Option?","category":"company","datetime":1785166802,"headline":"PAHC vs. SYK: Which Stock Is the Better Value Option?"}, {"id":141033951,"url":"https://finnhub.io/api/news?id=fcecda06d78a64160b71a7c83b72c3f8c835a6e8f5af835e1d1b85f851c8ee0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.","category":"company","datetime":1785158111,"headline":"Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS"}, {"id":141033952,"url":"https://finnhub.io/api/news?id=e1356cc922d24b2065e4fc35f5b4985c2626ea5c847c8e830a021f485c0ba596","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure demand as investors watch for earnings and margin trends.","category":"company","datetime":1785157260,"headline":"Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders"}, {"id":141011008,"url":"https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SYK","summary":"Get the weekly dividend update for Champions, Contenders & Challengers—read about the dividend changes, upcoming ex-dividend dates and pay dates here.","category":"company","datetime":1784916411,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"}, {"id":141005276,"url":"https://finnhub.io/api/news?id=fce891feb90878c9b568365dc8ab8155bd45866a90ca9d2b3a5d6fc1f72863eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.","category":"company","datetime":1784897252,"headline":"Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?"}, {"id":141017280,"url":"https://finnhub.io/api/news?id=76d2787cc2237b397d2f26adc0684909ea937123a4b2b20124117fe4fa5e2b68","image":"https://cdn.benzinga.com/files/images/story/2026/07/24/24-7-2026-111735-thebambooworks-com.jpg?width=2048&height=1536","source":"Benzinga","related":"SYK","summary":"The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses\n\n\n\n\n\n\n\nimage credit: Bamboo Works\n\n\n\nKey Takeaways:\n\n\n\n\nMicroPort MedBot","category":"company","datetime":1784897088,"headline":"MicroPort MedBot To Report First-Ever Profit On Booming Exports"}, {"id":140997733,"url":"https://finnhub.io/api/news?id=74d97e4def4c98d768ccd094d979fd3873c5ca18e7d51d9299d8c49e4fed8b7b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Qualcomm, Intuitive Surgical and Stryker lead today's top analyst reports, spotlighting growth drivers, strategic initiatives and ongoing challenges.","category":"company","datetime":1784817900,"headline":"The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants"}, {"id":140988153,"url":"https://finnhub.io/api/news?id=f12b46768222b60cc0e5cc0ad5a8a82c6ef823fd74cb0af6ee75633f8d102550","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"QUALCOMM is expanding beyond smartphones with growth in automotive, edge AI and data centers, but competition and weak China demand remain key challenges.","category":"company","datetime":1784753640,"headline":"Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker"}, {"id":140974912,"url":"https://finnhub.io/api/news?id=bbdead80568b813174817288369cedcdbc1558cbe69a3fa5d808987e69a9b82d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The market is offering a steep discount on this medical device maker, but the price tag comes with a story about slowing growth. Here’s how to read it.","category":"company","datetime":1784660157,"headline":"Why BSX Stock Hands You So Much Cash Right Now"}, {"id":140974913,"url":"https://finnhub.io/api/news?id=aa203e7f28d79433427fb12950820e559672ed5b69c0e2a20f702bef68a97fcc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.","category":"company","datetime":1784659383,"headline":"ISRG Stock: The Math Hidden In Its Price"}, {"id":140970510,"url":"https://finnhub.io/api/news?id=417bfdbec370b20b7e87a80f159cd76c2d10f705358575971728f4e520ddbf47","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"NZS shifts capital toward AI infrastructure and healthcare leaders","category":"company","datetime":1784636527,"headline":"Nvidia Returns to NZS Growth Fund"}, {"id":140963421,"url":"https://finnhub.io/api/news?id=6ea0dd033658292f48582a592a40caa31066d357172a543dd20d199c2861cc74","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.","category":"company","datetime":1784574905,"headline":"The Robot Maker's Paradox"}, {"id":140963423,"url":"https://finnhub.io/api/news?id=26047126ae59bd8c4eb72c217ec847dd194744894cd020aa98db1bbb6da3a19e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.","category":"company","datetime":1784571665,"headline":"What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?"}, {"id":140958769,"url":"https://finnhub.io/api/news?id=1e780a5396652a26af12c43d63de943d5bbdd6ac1d228864b9cc1b0bedf0fcf1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"LARGO, Fla., July 20, 2026--CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL.","category":"company","datetime":1784545200,"headline":"CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting"}, {"id":140962422,"url":"https://finnhub.io/api/news?id=5580413bb66938372e33afb5c6bebf77eb21224e311db5a3ece505b10699aa95","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536","source":"Benzinga","related":"SYK","summary":"Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.04% on an annualized basis producing an average annual return of 10.3%. Currently, Stryker has a market capitalization of $122.02 billion.","category":"company","datetime":1784543421,"headline":"Here’s How Much You Would Have Made Owning Stryker Stock In The Last 20 Years"}, {"id":140944900,"url":"https://finnhub.io/api/news?id=e77d76f3434f17b44a7271a4b4178cd3a084000ccbc8170e1df151c1706c49f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while market based multiples look closer to fair. Over five years, Stryker has returned 28.3%, which points to steady but not dramatic long term gains for shareholders. New products such as the Mako RPS handheld robotic system can support expectations for future cash...","category":"company","datetime":1784394439,"headline":"Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings"}, {"id":140940547,"url":"https://finnhub.io/api/news?id=c2585392dea75a3bc277f15d8952bba6cd6eb3516ae5a01c7312595cfaa19a1b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move extends the Mako ecosystem beyond robotic-arm systems into handheld robotics, potentially broadening adoption by matching robotic precision with familiar surgical workflows. Next, we’ll explore how expanding the...","category":"company","datetime":1784344509,"headline":"Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK)"}, {"id":140940111,"url":"https://finnhub.io/api/news?id=ebe2202ade933d00e63044350229e08b82e7db86b01a7ae08cdabb4732e1e7be","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements that extends its established Mako orthopaedic robotics portfolio. See our latest analysis for Stryker. The U.S. launch of Mako RPS comes as Stryker’s share price sits at US$319.87 after a recent pullback, with a 30 day share price return of 6.22% but a 1 year total shareholder return that declined 17.02%. This suggests enthusiasm around its...","category":"company","datetime":1784336914,"headline":"Stryker (SYK) Launches Mako RPS As Its Valuation Story Comes Into Focus"}, {"id":140934568,"url":"https://finnhub.io/api/news?id=fcdbb1523ac61c565eff444a9974ae081ef0444ebc3b4e416bbf2d2d7408ab7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.","category":"company","datetime":1784302740,"headline":"Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio"}, {"id":140932266,"url":"https://finnhub.io/api/news?id=bc48e208cd7cac737074967fd46726fff9d7dd46876f110ecebbbbbf9412e7ff","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"SYK","summary":"Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.","category":"company","datetime":1784298901,"headline":"These S&P500 stocks are gapping in today's session"}, {"id":140932973,"url":"https://finnhub.io/api/news?id=0504e442cf7f265bb43b0e44d54c0386af3ed0aa7fd4f592d362e90177bbdfa3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"JNJ beats Q2 estimates and raises 2026 guidance, but shares fall as MedTech misses expectations. Find out what weighed on the unit and what's next.","category":"company","datetime":1784298660,"headline":"J&J Stock Falls Despite Strong Q2 Beat & Higher 2026 View: Here's Why"}, {"id":140111723,"url":"https://finnhub.io/api/news?id=c6a02a2441034d13c97bae14c10063c3d4dedcc3d5c1f87702392bc91f1896e7","image":"","source":"Benzinga","related":"SYK","summary":"","category":"company","datetime":1784291136,"headline":"GE HealthCare Technologies shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS and lowered its FY2026 adjusted EPS guidance."}, {"id":140920976,"url":"https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.","category":"company","datetime":1784210345,"headline":"Why Abbott Stock Is Reimagining Its Future"}, {"id":140919929,"url":"https://finnhub.io/api/news?id=331a94af61a8277087847eb57290e1a52ef46de16da33713fb098788bd0f19de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (NYSE: SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement procedures, further expanding the Mako portfolio into a new category of orthopaedic robotics.","category":"company","datetime":1784207100,"headline":"Stryker expands Mako robotics portfolio with full market release of Mako RPS"}, {"id":140049019,"url":"https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed","image":"","source":"Benzinga","related":"SYK","summary":"","category":"company","datetime":1784205329,"headline":"Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"}, {"id":140912813,"url":"https://finnhub.io/api/news?id=af3b9436f23bb6328aa43e6b3e1faf8d7dd198364bfa6e28cf7cd911df9289f9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.","category":"company","datetime":1784140381,"headline":"The Open Questions On ISRG Stock"}, {"id":140911296,"url":"https://finnhub.io/api/news?id=aee602b293e01bdae62f2d6674938ab67845e74bf45b3536a1bd3aa55fdad064","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Johnson & Johnson stock dipped early Wednesday, though the healthcare giant beat second-quarter forecasts and raised its outlook.","category":"company","datetime":1784134793,"headline":"J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others"}, {"id":140906847,"url":"https://finnhub.io/api/news?id=922de0113b1b98ef15feee5ce7b9d228ed7c895637d059a927c88ef957dcf758","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"When Iranian-linked hackers breached medical device maker Stryker in March 2026, they did not need a sophisticated zero-day exploit to cause chaos. Once inside, they triggered simultaneous factory resets on more than 200,000 corporate devices across 79 countries, grinding order processing, production and shipping to a halt for days. Two months later, Foxconn confirmed that the Nitrogen ransomware group had stolen an alleged 8 terabytes of data from its North American factories, including project","category":"company","datetime":1784102400,"headline":"Independent Testing Shows Which Business Security Products Actually Hold Up When It Matters"}, {"id":140901598,"url":"https://finnhub.io/api/news?id=1c30ec9fc5eaa65b249de9077cf426329d566c616ac5f9591f0e7f9ba8098349","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.","category":"company","datetime":1784058057,"headline":"Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble"}, {"id":140901109,"url":"https://finnhub.io/api/news?id=deff9c90bb7e909239d4818d05eb00911aa88c16bd160a2315a273ea8e21cb70","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.","category":"company","datetime":1784055900,"headline":"Discover which S&P500 stocks are making waves on Tuesday."}, {"id":140901466,"url":"https://finnhub.io/api/news?id=3b28393a5831026f9ac3732237381ea888082eee864a93bb498cf961a423a22f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.","category":"company","datetime":1784052407,"headline":"The Paid-To-Hold Play On ISRG Stock: A 12% Income"}, {"id":140898964,"url":"https://finnhub.io/api/news?id=76a3fb9d03f8bf894bf401ec3d9d7e7a7980e4769b9be8dd004e0986d25fa30d","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.","category":"company","datetime":1784046901,"headline":"These S&P500 stocks are moving in today's session"}, {"id":140897584,"url":"https://finnhub.io/api/news?id=e89def7c0ac59e2c2278d3bdc4ee12a87bb928101e8b6a227c378a65a8572717","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"SYK","summary":"Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.","category":"company","datetime":1784039701,"headline":"What's going on in today's session: S&P500 gap up and gap down stocks"}, {"id":140091407,"url":"https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f","image":"","source":"Benzinga","related":"SYK","summary":"","category":"company","datetime":1784034450,"headline":"Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"}, {"id":140896860,"url":"https://finnhub.io/api/news?id=69cac81872a917b82ac0a4526f38f4b08928a2ae81ab419989126f3ac804ca95","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.","category":"company","datetime":1784033543,"headline":"ISRG Stock: What Does Its Valuation Imply?"}, {"id":140885071,"url":"https://finnhub.io/api/news?id=71b31314daf117ab4b7a113eb37cfe524f5210f5754749ce4767d53f3ef0320c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Opportunities in the nerve repair biomaterials market include advancements in regenerative medicine, rising demand for minimally invasive procedures, and smart biomaterials integration. Growth is driven by increased traumatic brain injuries, aging populations, and regional expansion, especially in Asia-Pacific. Nerve Repair Biomaterials Market Nerve Repair Biomaterials Market Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The \"Nerve Repair Biomaterials Market Report 2026\" has been added to ResearchAn","category":"company","datetime":1783942080,"headline":"Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players"}, {"id":140865362,"url":"https://finnhub.io/api/news?id=190546a100126c6d960166a6da62d4ab071710c348633046d16e808216573c23","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.","category":"company","datetime":1783707000,"headline":"ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?"}, {"id":140857121,"url":"https://finnhub.io/api/news?id=d5da76e3d463a1659eb229b2fb369439662f69c42499cdfd038f9ac17e2e5543","image":"","source":"Fintel","related":"SYK","summary":"","category":"company","datetime":1783645922,"headline":"BMO Capital Initiates Coverage of Stryker (SYK) with Outperform Recommendation"}, {"id":140854814,"url":"https://finnhub.io/api/news?id=11054f196b0e32b5c2809d2d7a6f50cab93df0a950a9feb5bb887db5b936089a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (NYSE:SYK) has been removed from multiple Russell growth indices following the latest rebalancing. The company recently faced a cyberattack that disrupted certain operations. Despite the index exits and cyber incident, some active investors have shown renewed interest in the stock. These shifts may influence trading volumes and how both passive and active funds approach NYSE:SYK. Stryker is a large medical technology company focused on surgical equipment, orthopedics and related...","category":"company","datetime":1783624224,"headline":"Stryker (SYK) Stock Loses Russell Growth Slots As Active Investors Step In"}, {"id":140856698,"url":"https://finnhub.io/api/news?id=a0e9022521464a80a09aceb92a9e4ff94ca4114c58c5fbd73d33dc98e37a81ab","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker is set to post its second-quarter results later this month, and analysts project a double-digit earnings growth.","category":"company","datetime":1783614433,"headline":"Stryker's Quarterly Earnings Preview: What You Need to Know"}, {"id":140853728,"url":"https://finnhub.io/api/news?id=afb7bb7649d73fdfc58e4a1c34838d3a219a2539822045c42434a80349996b22","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here. The global equity market continued its rally in May, driven by accelerating AI infrastructure spending and a stronger-than-expected earnings season. The Fund (Platform Class) returned 2.1%, underperforming the MSCI World ex-Australia Index’s 4.5% […]","category":"company","datetime":1783613050,"headline":"Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance"}, {"id":140852295,"url":"https://finnhub.io/api/news?id=33fcda0f34cf71ba33bf1f5fd26dd4a8a1bface677ea2b2eba3a0ad455a486ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The orthopedic surgical robots market presents growth opportunities in AI integration, digital workflows, and minimally invasive procedures. Key areas include knee, hip, spine, and shoulder robotics, with significant regional potential in Asia-Pacific and North America. Focus areas include innovation, ESG, and training. Orthopedic Surgical Robots Market Orthopedic Surgical Robots Market Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The \"Global Orthopedic Surgical Robots Market\" has been added to Res","category":"company","datetime":1783608240,"headline":"Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic"}, {"id":140852127,"url":"https://finnhub.io/api/news?id=3dc0ae22f59ecc076a1a15b91bdc68fa65b5f68b674058d014aa38fddece5920","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"If you hold shares in this medical device maker, you are already carrying the full weight of a sizable potential swing that the market is pricing for the year ahead.","category":"company","datetime":1783604422,"headline":"The Wide Chasm Priced Into Boston Scientific Stock"}, {"id":140850835,"url":"https://finnhub.io/api/news?id=9966738aa03e2c1d7bf64189594dd665e4ed1896a9b982f1abb0e878f0e60f2b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"The options market has priced a sizable range of outcomes for the surgical robotics leader, and if you hold the shares, you are already carrying that full exposure.","category":"company","datetime":1783603762,"headline":"Just How Much Risk Is Built Into ISRG Stock?"}, {"id":140862585,"url":"https://finnhub.io/api/news?id=9df177a926fa1613790508f8a644ff4e09abe2c1402fb138291157d67a54c1ab","image":"","source":"Benzinga","related":"SYK","summary":"BMO Capital initiates coverage on Stryker (NYSE:SYK) with a Outperform rating and announces Price Target of $369.","category":"company","datetime":1783592223,"headline":"BMO Capital Initiates Coverage On Stryker with Outperform Rating, Announces Price Target of $369"}, {"id":140850500,"url":"https://finnhub.io/api/news?id=abd5251e75e6785b9c62af971b1d6f692745a5486eed4c6d763d18f9e5bce35f","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2248458314/image_2248458314.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SYK","summary":"Stryker (SYK) buy rating after a rare Q1 miss from a temporary cyber disruption. Full-year guidance holds; demand strong.","category":"company","datetime":1783588719,"headline":"Stryker: The Market Is Overreacting To One Disrupted Quarter"}, {"id":140844394,"url":"https://finnhub.io/api/news?id=ab294aeeedf3bdd2dc056a6141333f005547f7b51c858f341bb42fee42682199","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Rising use of automation in healthcare is reshaping robotics ETFs as med-tech innovators gain prominence.","category":"company","datetime":1783533840,"headline":"Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs"}, {"id":140843377,"url":"https://finnhub.io/api/news?id=0c81e90fd0177693e04c6f597f3094721aad21cf484f4f5e2f07a9365658f254","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"If you hold shares in this surgical robotics leader, you are already carrying a sizable two-sided risk, whether you trade options or not.","category":"company","datetime":1783528899,"headline":"Just How Wide Is The Path Ahead For Intuitive Surgical Stock?"}, {"id":140843499,"url":"https://finnhub.io/api/news?id=34d6969d4b2f1003b268bcd94b1089a6f9c61146cfa33106e1f253c389d29e9a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"ICUI vs. SYK: Which Stock Is the Better Value Option?","category":"company","datetime":1783525203,"headline":"ICUI vs. SYK: Which Stock Should Value Investors Buy Now?"}, {"id":140839793,"url":"https://finnhub.io/api/news?id=303ee684ee433beba364a488812c644cbdf27564c78a5b59a237e3643f317e29","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172700619/image_2172700619.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SYK","summary":"Stryker stock looks undervalued with a 13% discount to fair value, a strong EPS growth outlook, and dividend potential. Click for more on SYK stock.","category":"company","datetime":1783497600,"headline":"Stryker: Medtech On Sale, Benefiting From Industry Growth"}, {"id":140833104,"url":"https://finnhub.io/api/news?id=f73d9bb5aecbe9b69580b1a7d34036b80a10531a82d3d18ec22b3063bbc2320c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.","category":"company","datetime":1783441260,"headline":"How Big Is the Appendectomy Opportunity for ISRG's Robotic Expansion?"}, {"id":140831587,"url":"https://finnhub.io/api/news?id=9d4adf0658bcfc2f9d524c005dd79c6afe5127eb5c50b2e91137e17ec21f9ab1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Delray Beach, FL, July 07, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global orthopedic devices market will grow from USD 51.61 billion in 2024 to USD 68.51 billion by 2030, at a CAGR of 4.8% during the forecast period. Market growth is fueled by the rising prevalence of musculoskeletal disorders, increasing geriatric population, growing demand for minimally invasive orthopedic procedures, and continuous technological advancements including robotic-assisted surgeries and smart orth","category":"company","datetime":1783435500,"headline":"Orthopedic Devices Market to Grow from USD 51.61 Billion in 2024 to USD 68.51 Billion by 2030, at a CAGR of 4.8% - MarketsandMarkets™"}, {"id":140830065,"url":"https://finnhub.io/api/news?id=3c61c162eeb4a4ff55bbbf7eb416d76bd56a1411992abae065eed559761e61eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.","category":"company","datetime":1783430548,"headline":"How To Target A 10% Yield While Catching The BSX Stock Knife?"}, {"id":140821047,"url":"https://finnhub.io/api/news?id=2912828987debfe482d154cb8869250ceca30533455825d752a5f8b801edaad6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.","category":"company","datetime":1783351875,"headline":"Intuitive Surgical Stock Looks Weighed Down. Its After-Hours Growth Says Otherwise."}, {"id":140822462,"url":"https://finnhub.io/api/news?id=fb503b298eddbe55fa669632c0bf8202960ac03b9180070af394c3342a8ad8b7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"JNJ's Q2 MedTech results will test whether cardiovascular, surgery and vision strength can offset ongoing China VBP headwinds and sustain growth.","category":"company","datetime":1783349880,"headline":"J&J's MedTech Segment Eyes Another Strong Quarter in Q2"}, {"id":140825068,"url":"https://finnhub.io/api/news?id=3f55e9cbd2d456f75646822ef44c175b5e6878f63987e49b585dc6265c1077e5","image":"","source":"Benzinga","related":"SYK","summary":"Evercore ISI Group analyst Vijay Kumar maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $355 to $350.","category":"company","datetime":1783342719,"headline":"Evercore ISI Group Maintains Outperform on Stryker, Lowers Price Target to $350"}, {"id":140818838,"url":"https://finnhub.io/api/news?id=4a9dad0cdd3d6382d067ef903737da740abba78f9122b0856f78660880f6c0b9","image":"https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp","source":"ChartMill","related":"SYK","summary":"When searching for dividend stocks, avoid high-yield traps. Stryker (SYK) offers a sustainable 1.08% yield with strong 7.89% annual growth, solid profitability, and a healthy payout ratio.","category":"company","datetime":1783335033,"headline":"Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income"}, {"id":140821122,"url":"https://finnhub.io/api/news?id=bc1a01e4a3153aeaa577fecd21bc76829a5c301b0d3227ab5365e40dcf8bb30d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.","category":"company","datetime":1783332000,"headline":"Top 10 medtech deals in the first half of 2026"}, {"id":140807143,"url":"https://finnhub.io/api/news?id=a602ea2eae629270a77afc0aa10501bc1cda26cc95a9263acdfdcd32bc4d4450","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker Corp (NYSE:SYK) is one of the best robotics stocks to buy. On June 12, BTIG analyst Ryan Zimmerman reiterated a Buy rating and a $379 price target on Stryker Corp (NYSE:SYK). The price target represents significant upside potential as the stock is trading at about $316 a share. The bullish stance comes on the […]","category":"company","datetime":1783172856,"headline":"Is Stryker Corp. (SYK) The Best Robotic Stock to Buy?"}, {"id":140794039,"url":"https://finnhub.io/api/news?id=8831e57c447685f7d89edb07b4c239f2b6fa697dd0711d22279e85d63efc7d36","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"While a guidance cut has reset expectations, several core Boston Scientific franchises are accelerating. The Neuromodulation and Interventional Oncology businesses both posted organic sales growth of 15% last quarter. This internal momentum in high-value categories contrasts sharply with the new, more cautious company-wide outlook.","category":"company","datetime":1783013922,"headline":"What Could Push BSX Stock Higher From Here?"}, {"id":140789827,"url":"https://finnhub.io/api/news?id=0fb14c188d8c67b97d0d1a1e96422d17565cd40e09bbf6a93265a6ffd02b1349","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.","category":"company","datetime":1782990024,"headline":"1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges"}, {"id":140788777,"url":"https://finnhub.io/api/news?id=9a39c2abc725d4de8ebd5d279d74ed883a91ec0a741e35cb36275b53cba2213e","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215945492/image_2215945492.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SYK","summary":"Stryker looks undervalued after a cyber incident, with 32 years of dividend hikes, strong cash flow and M&A growth. Learn more on SYK stock here.","category":"company","datetime":1782969939,"headline":"Stryker: The Reshaped Product Portfolio Will Drive Growth"}, {"id":140780530,"url":"https://finnhub.io/api/news?id=d0fe8c0ba178e00be1e131acac41a495e6ce7890f6beb2590347eb46bd0642ff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (NYSE:SYK) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results. Stryker absorbed a March 11 cyberattack and heavy restructuring charges while defending its joint replacement franchise. Intuitive posted another crisp beat on the back of da Vinci 5 adoption. Two medtech giants, two very different quarters. A Cyber ... Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation","category":"company","datetime":1782918871,"headline":"Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation"}, {"id":140779549,"url":"https://finnhub.io/api/news?id=11dd89d9640d405a6f6db7f49162e5b0b4036c8385e032b06056d3e009346d25","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter","category":"company","datetime":1782907200,"headline":"Stryker to announce second quarter 2026 financial results"}, {"id":140774276,"url":"https://finnhub.io/api/news?id=1607dff3285f4bc45cf8ebe7c9ed22e9600f5e1d933634515c11aa2327149b00","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.","category":"company","datetime":1782846300,"headline":"Top S&P500 movers in Tuesday's session"}, {"id":140780221,"url":"https://finnhub.io/api/news?id=e5084c428cf75b8d527a4321c3cd00c93238e849646ed673fd49736eae9ec65c","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536","source":"Benzinga","related":"SYK","summary":"Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.17% on an annualized basis producing an average annual return of 10.45%. Currently, Stryker has a market capitalization of $120.58 billion.","category":"company","datetime":1782839729,"headline":"If You Invested $1000 In Stryker Stock 20 Years Ago, You Would Have This Much Today"}, {"id":140773254,"url":"https://finnhub.io/api/news?id=45ffab8e93f60bba9fc6207e83277e70f09ef21e40612c43f8cf49acb4ed4d4b","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SYK","summary":"Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.","category":"company","datetime":1782837301,"headline":"Which S&P500 stocks are moving on Tuesday?"}, {"id":140772070,"url":"https://finnhub.io/api/news?id=17bd4c797ef7cc747361285011496ed1a3e9002a5368b53bcc55e268c39f4406","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"If you are wondering whether Stryker stock is offering fair value or a potential opportunity right now, the key is understanding what the current price is actually reflecting. The stock last closed at US$330.52, with returns of 8.5% over the past week and 8.3% over the past month, while the return year to date is down 5.1% and the return over the past year is down 15.6%. Recent headlines around Stryker have kept the stock on many investors' watchlists, as the company continues to sit at the...","category":"company","datetime":1782821256,"headline":"Stryker (SYK) Stock Weighs DCF Upside Against High P/E After Recent Price Rebound"}, {"id":140771630,"url":"https://finnhub.io/api/news?id=53e8a8231d3d21ce976866bd5f78c9ea51437b2410288a7e04d3527dd6887dba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"On 27 June 2026, Stryker Corporation was removed from multiple Russell growth indexes, including the Russell 1000 Growth, Russell 3000 Growth, Russell Top 200 Growth, and Russell 3000E Growth benchmarks. This broad index removal matters because it can trigger compulsory selling by index-tracking funds, reshaping who owns Stryker shares and how they trade. Next, we’ll examine how Stryker’s removal from several Russell growth benchmarks could influence its existing investment narrative and...","category":"company","datetime":1782814041,"headline":"Stryker (SYK) Is Up 8.5% After Broad Russell Growth Index Removal Reshapes Its Shareholder Base"}, {"id":140765525,"url":"https://finnhub.io/api/news?id=27063d3a286c41bc95f3fbd723af7d076927548982493424e81d400666ffb8d9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Is SYK a good stock to buy? We came across a bullish thesis on Stryker Corporation on MaxDividends’s Substack by Serhio MaxDividends. In this article, we will summarize the bulls’ thesis on SYK. Stryker Corporation’s share was trading at $313.68 as of June 24th. SYK’s trailing and forward P/E were 36.31 and 20.92 respectively according to Yahoo […]","category":"company","datetime":1782761641,"headline":"Is Stryker Corporation (SYK) A Good Stock To Buy Now?"}, {"id":140760902,"url":"https://finnhub.io/api/news?id=66e0acb534e9a1dd7c85fafcb27df8a2e8fd35dcf3135e76cfb2189a79f0a166","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.","category":"company","datetime":1782726540,"headline":"Stryker (SYK) Moves 5.3% Higher: Will This Strength Last?"}, {"id":140756685,"url":"https://finnhub.io/api/news?id=b035ec48a96b8e72493d5c19bc3a8486393fbc86e5d0fa25b90ff18b5b10be1d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SYK","summary":"Stryker Corporation (NYSE:SYK) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds. On June 2, Stryker Corporation (NYSE:SYK) announced the launch of TPX HD. It is a small bone power tool designed for demanding orthopaedic procedures, including total joint revisions, minimally invasive surgery, and oral maxillofacial procedures. Mike Carlin, […]","category":"company","datetime":1782676687,"headline":"Stryker Corporation (SYK) launches TPX HD® Power Tool"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 2
recomputed_at_score true
sentiment_score_raw 0.6
source_article_count 73
discarded_article_count 57
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.5 5/110 70% 3.5
資金流 12.4 20/110 62% 12.4
市場環境 3.6 15/110 24% 3.6
催化劑 2 20/110 10% 2
風險管理 6.5 10/110 65% 6.5
技術信號 21.9 30/110 73% 21.9
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 22/50
ret_5d 0.0551
max_score 50
max_total 50
raw_total 22
vcp_bonus 0
vol_ratio 0.6286
ret_points 8
vol_points 0
range_ratio 0.6598
volat_points 0
day_range_pct 0.0202
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 8
partial_history false
pullback_points 3
breakout_vol_bonus 0
first_breakout_20d true
return_window_days 5
first_breakout_bonus 2
breakout_quality_points 1

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.3

details

atrPct 3.0373
turnoverUsdM 553.9827
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.SYK
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 316.2842

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 6.1
take_profit_price 360.0596
target_multiplier 1.9
technical_strength 1.8
take_profit_percent 6.9
positionPoints 1.3
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.0747
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.5/5分
資金流分析總分: 12.4/20分
市場環境分析總分: 3.6/15分
催化劑分析: 2/20分
風險管理總分: 6.5/10分
技術信號分析總分: 21.9/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 10.2279
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.04
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 132.98
cmf
rule Cursor_18.24 CMF bands
level 平衡
score 4
value 0.0402
kdj
d 51.46
j 91.7
k 64.87
rule Cursor_18.24 K/D cross
score 6
signal 強金叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 51.34
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 14171135
recentSlope 389733.5
previousSlope -231480
rsi
value 53.59
sar
rule Cursor_18.24 Parabolic SAR
score 10
trend 上升
value 306.53
position SAR由上轉下+趨勢強
distancePct 8.97
previousTrend 下降
ma50
value 314.6064
macd
macd 2.9802
trend 強烈看漲
signal 2.6124
histogram 0.3677
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 6
value 322.3014
position 連續1-2日>VWAP
consecutiveAbove 2
volume
rule Cursor_18.24 volume ratio
level 空升
ratio 0.68
score 2
avgVolume 2424077
currentVolume 1645135
derived
ma20 323.1225
ma50 314.6064
prevClose 330.25
avgVolume10 2326474
avgVolume20 2424077
changePercent 1.97
avgVolumeForScore 2424077
ma_cross
ma20 323.1225
ma50 314.6064
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 322.921
prevMa50 313.9134
spreadPct 2.71
isVolumeBreakout false
bollinger
lower 307.4998
upper 338.7452
position 上半部
rsi_short
value 72.12
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.68

Raw calculation JSON

 
{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.037328592900416,
        "turnoverUsdM": 553.98274344865,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.SYK",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 316.2842,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 6.1,
      "take_profit_price": 360.0596,
      "target_multiplier": 1.9,
      "technical_strength": 1.8,
      "take_profit_percent": 6.9
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.074657185800832,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 75.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 53.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 22
  },
  "market": {
    "ma20": 323.1225,
    "ma50": 314.6064,
    "close": 336.74,
    "prevClose": 330.25,
    "avgVolume20": 2424077,
    "volumeRatio": 0.68,
    "changePercent": 1.97
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 22,
    "details": {
      "ret_5d": 0.055148146420124444,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 22,
      "vcp_bonus": 0,
      "vol_ratio": 0.6285834915807291,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 0.6598463965921628,
      "volat_points": 0,
      "day_range_pct": 0.020208440345918025,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 1
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 75.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 70,
        "contribution": 3.5
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 3.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 24,
        "contribution": 3.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.5,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 65,
        "contribution": 6.5
      },
      {
        "raw": 21.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 73,
        "contribution": 21.9
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 53.9,
    "details": [
      "基本面分析總分: 3.5/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 3.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.5/10分",
      "技術信號分析總分: 21.9/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.5,
      "資金流": 12.4,
      "市場環境": 3.6,
      "情緒分析": 4,
      "技術信號": 21.9,
      "風險管理": 6.5
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.6,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 553.98274344865,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 2.4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.SYK",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 710.4899991500001,
                "ma50": 717.6342017599999,
                "name": "QQQ",
                "close": 682.059998,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.6545068500001,
                "ma50": 745.00220184,
                "name": "SPY",
                "close": 739.02002,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.037328592900416,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141035262,
                "url": "https://finnhub.io/api/news?id=3647e16ddb54bcb74608f6e6fedc1a1a9698d86be7c61a3e3fdbb16221dff9ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "PAHC vs. SYK: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1785166802,
                "headline": "PAHC vs. SYK: Which Stock Is the Better Value Option?"
              },
              {
                "id": 141033951,
                "url": "https://finnhub.io/api/news?id=fcecda06d78a64160b71a7c83b72c3f8c835a6e8f5af835e1d1b85f851c8ee0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785158111,
                "headline": "Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS"
              },
              {
                "id": 140944900,
                "url": "https://finnhub.io/api/news?id=e77d76f3434f17b44a7271a4b4178cd3a084000ccbc8170e1df151c1706c49f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while market based multiples look closer to fair. Over five years, Stryker has returned 28.3%, which points to steady but not dramatic long term gains for shareholders. New products such as the Mako RPS handheld robotic system can support expectations for future cash...",
                "category": "company",
                "datetime": 1784394439,
                "headline": "Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings"
              },
              {
                "id": 140940547,
                "url": "https://finnhub.io/api/news?id=c2585392dea75a3bc277f15d8952bba6cd6eb3516ae5a01c7312595cfaa19a1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move extends the Mako ecosystem beyond robotic-arm systems into handheld robotics, potentially broadening adoption by matching robotic precision with familiar surgical workflows. Next, we’ll explore how expanding the...",
                "category": "company",
                "datetime": 1784344509,
                "headline": "Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK)"
              },
              {
                "id": 140940111,
                "url": "https://finnhub.io/api/news?id=ebe2202ade933d00e63044350229e08b82e7db86b01a7ae08cdabb4732e1e7be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements that extends its established Mako orthopaedic robotics portfolio. See our latest analysis for Stryker. The U.S. launch of Mako RPS comes as Stryker’s share price sits at US$319.87 after a recent pullback, with a 30 day share price return of 6.22% but a 1 year total shareholder return that declined 17.02%. This suggests enthusiasm around its...",
                "category": "company",
                "datetime": 1784336914,
                "headline": "Stryker (SYK) Launches Mako RPS As Its Valuation Story Comes Into Focus"
              },
              {
                "id": 140857121,
                "url": "https://finnhub.io/api/news?id=d5da76e3d463a1659eb229b2fb369439662f69c42499cdfd038f9ac17e2e5543",
                "image": "",
                "source": "Fintel",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1783645922,
                "headline": "BMO Capital Initiates Coverage of Stryker (SYK) with Outperform Recommendation"
              },
              {
                "id": 140854814,
                "url": "https://finnhub.io/api/news?id=11054f196b0e32b5c2809d2d7a6f50cab93df0a950a9feb5bb887db5b936089a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) has been removed from multiple Russell growth indices following the latest rebalancing. The company recently faced a cyberattack that disrupted certain operations. Despite the index exits and cyber incident, some active investors have shown renewed interest in the stock. These shifts may influence trading volumes and how both passive and active funds approach NYSE:SYK. Stryker is a large medical technology company focused on surgical equipment, orthopedics and related...",
                "category": "company",
                "datetime": 1783624224,
                "headline": "Stryker (SYK) Stock Loses Russell Growth Slots As Active Investors Step In"
              },
              {
                "id": 140853728,
                "url": "https://finnhub.io/api/news?id=afb7bb7649d73fdfc58e4a1c34838d3a219a2539822045c42434a80349996b22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here. The global equity market continued its rally in May, driven by accelerating AI infrastructure spending and a stronger-than-expected earnings season. The Fund (Platform Class) returned 2.1%, underperforming the MSCI World ex-Australia Index’s 4.5% […]",
                "category": "company",
                "datetime": 1783613050,
                "headline": "Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance"
              }
            ],
            "raw_source": [
              {
                "id": 141035129,
                "url": "https://finnhub.io/api/news?id=c92ef4a473af545abf93085c0feb833d345113b7ee6e12a65912c65c41f0d0ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.",
                "category": "company",
                "datetime": 1785167220,
                "headline": "J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?"
              },
              {
                "id": 141035262,
                "url": "https://finnhub.io/api/news?id=3647e16ddb54bcb74608f6e6fedc1a1a9698d86be7c61a3e3fdbb16221dff9ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "PAHC vs. SYK: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1785166802,
                "headline": "PAHC vs. SYK: Which Stock Is the Better Value Option?"
              },
              {
                "id": 141033951,
                "url": "https://finnhub.io/api/news?id=fcecda06d78a64160b71a7c83b72c3f8c835a6e8f5af835e1d1b85f851c8ee0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785158111,
                "headline": "Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS"
              },
              {
                "id": 141033952,
                "url": "https://finnhub.io/api/news?id=e1356cc922d24b2065e4fc35f5b4985c2626ea5c847c8e830a021f485c0ba596",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure demand as investors watch for earnings and margin trends.",
                "category": "company",
                "datetime": 1785157260,
                "headline": "Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders"
              },
              {
                "id": 141011008,
                "url": "https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SYK",
                "summary": "Get the weekly dividend update for Champions, Contenders & Challengers—read about the dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1784916411,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"
              },
              {
                "id": 141005276,
                "url": "https://finnhub.io/api/news?id=fce891feb90878c9b568365dc8ab8155bd45866a90ca9d2b3a5d6fc1f72863eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.",
                "category": "company",
                "datetime": 1784897252,
                "headline": "Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?"
              },
              {
                "id": 141017280,
                "url": "https://finnhub.io/api/news?id=76d2787cc2237b397d2f26adc0684909ea937123a4b2b20124117fe4fa5e2b68",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/24-7-2026-111735-thebambooworks-com.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses\n\n\n\n\n\n\n\nimage credit: Bamboo Works\n\n\n\nKey Takeaways:\n\n\n\n\nMicroPort MedBot",
                "category": "company",
                "datetime": 1784897088,
                "headline": "MicroPort MedBot To Report First-Ever Profit On Booming Exports"
              },
              {
                "id": 140997733,
                "url": "https://finnhub.io/api/news?id=74d97e4def4c98d768ccd094d979fd3873c5ca18e7d51d9299d8c49e4fed8b7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Qualcomm, Intuitive Surgical and Stryker lead today's top analyst reports, spotlighting growth drivers, strategic initiatives and ongoing challenges.",
                "category": "company",
                "datetime": 1784817900,
                "headline": "The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants"
              },
              {
                "id": 140988153,
                "url": "https://finnhub.io/api/news?id=f12b46768222b60cc0e5cc0ad5a8a82c6ef823fd74cb0af6ee75633f8d102550",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "QUALCOMM is expanding beyond smartphones with growth in automotive, edge AI and data centers, but competition and weak China demand remain key challenges.",
                "category": "company",
                "datetime": 1784753640,
                "headline": "Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker"
              },
              {
                "id": 140974912,
                "url": "https://finnhub.io/api/news?id=bbdead80568b813174817288369cedcdbc1558cbe69a3fa5d808987e69a9b82d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The market is offering a steep discount on this medical device maker, but the price tag comes with a story about slowing growth. Here’s how to read it.",
                "category": "company",
                "datetime": 1784660157,
                "headline": "Why BSX Stock Hands You So Much Cash Right Now"
              },
              {
                "id": 140974913,
                "url": "https://finnhub.io/api/news?id=aa203e7f28d79433427fb12950820e559672ed5b69c0e2a20f702bef68a97fcc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.",
                "category": "company",
                "datetime": 1784659383,
                "headline": "ISRG Stock: The Math Hidden In Its Price"
              },
              {
                "id": 140970510,
                "url": "https://finnhub.io/api/news?id=417bfdbec370b20b7e87a80f159cd76c2d10f705358575971728f4e520ddbf47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "NZS shifts capital toward AI infrastructure and healthcare leaders",
                "category": "company",
                "datetime": 1784636527,
                "headline": "Nvidia Returns to NZS Growth Fund"
              },
              {
                "id": 140963421,
                "url": "https://finnhub.io/api/news?id=6ea0dd033658292f48582a592a40caa31066d357172a543dd20d199c2861cc74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.",
                "category": "company",
                "datetime": 1784574905,
                "headline": "The Robot Maker's Paradox"
              },
              {
                "id": 140963423,
                "url": "https://finnhub.io/api/news?id=26047126ae59bd8c4eb72c217ec847dd194744894cd020aa98db1bbb6da3a19e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.",
                "category": "company",
                "datetime": 1784571665,
                "headline": "What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?"
              },
              {
                "id": 140958769,
                "url": "https://finnhub.io/api/news?id=1e780a5396652a26af12c43d63de943d5bbdd6ac1d228864b9cc1b0bedf0fcf1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "LARGO, Fla., July 20, 2026--CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL.",
                "category": "company",
                "datetime": 1784545200,
                "headline": "CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting"
              },
              {
                "id": 140962422,
                "url": "https://finnhub.io/api/news?id=5580413bb66938372e33afb5c6bebf77eb21224e311db5a3ece505b10699aa95",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.04% on an annualized basis producing an average annual return of 10.3%. Currently, Stryker has a market capitalization of $122.02 billion.",
                "category": "company",
                "datetime": 1784543421,
                "headline": "Here’s How Much You Would Have Made Owning Stryker Stock In The Last 20 Years"
              },
              {
                "id": 140944900,
                "url": "https://finnhub.io/api/news?id=e77d76f3434f17b44a7271a4b4178cd3a084000ccbc8170e1df151c1706c49f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker stock has given investors a 28.3% total return over the past five years, yet its current price around US$319.87 sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while market based multiples look closer to fair. Over five years, Stryker has returned 28.3%, which points to steady but not dramatic long term gains for shareholders. New products such as the Mako RPS handheld robotic system can support expectations for future cash...",
                "category": "company",
                "datetime": 1784394439,
                "headline": "Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings"
              },
              {
                "id": 140940547,
                "url": "https://finnhub.io/api/news?id=c2585392dea75a3bc277f15d8952bba6cd6eb3516ae5a01c7312595cfaa19a1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "On 16 July 2026, Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that combines intraoperative planning with a robotically enabled saw and integrates with its Triathlon Total Knee System and Q Guidance platform. This move extends the Mako ecosystem beyond robotic-arm systems into handheld robotics, potentially broadening adoption by matching robotic precision with familiar surgical workflows. Next, we’ll explore how expanding the...",
                "category": "company",
                "datetime": 1784344509,
                "headline": "Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK)"
              },
              {
                "id": 140940111,
                "url": "https://finnhub.io/api/news?id=ebe2202ade933d00e63044350229e08b82e7db86b01a7ae08cdabb4732e1e7be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (SYK) has drawn fresh attention after announcing the U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacements that extends its established Mako orthopaedic robotics portfolio. See our latest analysis for Stryker. The U.S. launch of Mako RPS comes as Stryker’s share price sits at US$319.87 after a recent pullback, with a 30 day share price return of 6.22% but a 1 year total shareholder return that declined 17.02%. This suggests enthusiasm around its...",
                "category": "company",
                "datetime": 1784336914,
                "headline": "Stryker (SYK) Launches Mako RPS As Its Valuation Story Comes Into Focus"
              },
              {
                "id": 140934568,
                "url": "https://finnhub.io/api/news?id=fcdbb1523ac61c565eff444a9974ae081ef0444ebc3b4e416bbf2d2d7408ab7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.",
                "category": "company",
                "datetime": 1784302740,
                "headline": "Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio"
              },
              {
                "id": 140932266,
                "url": "https://finnhub.io/api/news?id=bc48e208cd7cac737074967fd46726fff9d7dd46876f110ecebbbbbf9412e7ff",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1784298901,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 140932973,
                "url": "https://finnhub.io/api/news?id=0504e442cf7f265bb43b0e44d54c0386af3ed0aa7fd4f592d362e90177bbdfa3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "JNJ beats Q2 estimates and raises 2026 guidance, but shares fall as MedTech misses expectations. Find out what weighed on the unit and what's next.",
                "category": "company",
                "datetime": 1784298660,
                "headline": "J&J Stock Falls Despite Strong Q2 Beat & Higher 2026 View: Here's Why"
              },
              {
                "id": 140111723,
                "url": "https://finnhub.io/api/news?id=c6a02a2441034d13c97bae14c10063c3d4dedcc3d5c1f87702392bc91f1896e7",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1784291136,
                "headline": "GE HealthCare Technologies shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS and lowered its FY2026 adjusted EPS guidance."
              },
              {
                "id": 140920976,
                "url": "https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.",
                "category": "company",
                "datetime": 1784210345,
                "headline": "Why Abbott Stock Is Reimagining Its Future"
              },
              {
                "id": 140919929,
                "url": "https://finnhub.io/api/news?id=331a94af61a8277087847eb57290e1a52ef46de16da33713fb098788bd0f19de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (NYSE: SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement procedures, further expanding the Mako portfolio into a new category of orthopaedic robotics.",
                "category": "company",
                "datetime": 1784207100,
                "headline": "Stryker expands Mako robotics portfolio with full market release of Mako RPS"
              },
              {
                "id": 140049019,
                "url": "https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1784205329,
                "headline": "Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"
              },
              {
                "id": 140912813,
                "url": "https://finnhub.io/api/news?id=af3b9436f23bb6328aa43e6b3e1faf8d7dd198364bfa6e28cf7cd911df9289f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.",
                "category": "company",
                "datetime": 1784140381,
                "headline": "The Open Questions On ISRG Stock"
              },
              {
                "id": 140911296,
                "url": "https://finnhub.io/api/news?id=aee602b293e01bdae62f2d6674938ab67845e74bf45b3536a1bd3aa55fdad064",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Johnson & Johnson stock dipped early Wednesday, though the healthcare giant beat second-quarter forecasts and raised its outlook.",
                "category": "company",
                "datetime": 1784134793,
                "headline": "J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others"
              },
              {
                "id": 140906847,
                "url": "https://finnhub.io/api/news?id=922de0113b1b98ef15feee5ce7b9d228ed7c895637d059a927c88ef957dcf758",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "When Iranian-linked hackers breached medical device maker Stryker in March 2026, they did not need a sophisticated zero-day exploit to cause chaos. Once inside, they triggered simultaneous factory resets on more than 200,000 corporate devices across 79 countries, grinding order processing, production and shipping to a halt for days. Two months later, Foxconn confirmed that the Nitrogen ransomware group had stolen an alleged 8 terabytes of data from its North American factories, including project",
                "category": "company",
                "datetime": 1784102400,
                "headline": "Independent Testing Shows Which Business Security Products Actually Hold Up When It Matters"
              },
              {
                "id": 140901598,
                "url": "https://finnhub.io/api/news?id=1c30ec9fc5eaa65b249de9077cf426329d566c616ac5f9591f0e7f9ba8098349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.",
                "category": "company",
                "datetime": 1784058057,
                "headline": "Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble"
              },
              {
                "id": 140901109,
                "url": "https://finnhub.io/api/news?id=deff9c90bb7e909239d4818d05eb00911aa88c16bd160a2315a273ea8e21cb70",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1784055900,
                "headline": "Discover which S&P500 stocks are making waves on Tuesday."
              },
              {
                "id": 140901466,
                "url": "https://finnhub.io/api/news?id=3b28393a5831026f9ac3732237381ea888082eee864a93bb498cf961a423a22f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.",
                "category": "company",
                "datetime": 1784052407,
                "headline": "The Paid-To-Hold Play On ISRG Stock: A 12% Income"
              },
              {
                "id": 140898964,
                "url": "https://finnhub.io/api/news?id=76a3fb9d03f8bf894bf401ec3d9d7e7a7980e4769b9be8dd004e0986d25fa30d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.",
                "category": "company",
                "datetime": 1784046901,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 140897584,
                "url": "https://finnhub.io/api/news?id=e89def7c0ac59e2c2278d3bdc4ee12a87bb928101e8b6a227c378a65a8572717",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.",
                "category": "company",
                "datetime": 1784039701,
                "headline": "What's going on in today's session: S&P500 gap up and gap down stocks"
              },
              {
                "id": 140091407,
                "url": "https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1784034450,
                "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"
              },
              {
                "id": 140896860,
                "url": "https://finnhub.io/api/news?id=69cac81872a917b82ac0a4526f38f4b08928a2ae81ab419989126f3ac804ca95",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.",
                "category": "company",
                "datetime": 1784033543,
                "headline": "ISRG Stock: What Does Its Valuation Imply?"
              },
              {
                "id": 140885071,
                "url": "https://finnhub.io/api/news?id=71b31314daf117ab4b7a113eb37cfe524f5210f5754749ce4767d53f3ef0320c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Opportunities in the nerve repair biomaterials market include advancements in regenerative medicine, rising demand for minimally invasive procedures, and smart biomaterials integration. Growth is driven by increased traumatic brain injuries, aging populations, and regional expansion, especially in Asia-Pacific. Nerve Repair Biomaterials Market Nerve Repair Biomaterials Market Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The \"Nerve Repair Biomaterials Market Report 2026\" has been added to ResearchAn",
                "category": "company",
                "datetime": 1783942080,
                "headline": "Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players"
              },
              {
                "id": 140865362,
                "url": "https://finnhub.io/api/news?id=190546a100126c6d960166a6da62d4ab071710c348633046d16e808216573c23",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.",
                "category": "company",
                "datetime": 1783707000,
                "headline": "ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?"
              },
              {
                "id": 140857121,
                "url": "https://finnhub.io/api/news?id=d5da76e3d463a1659eb229b2fb369439662f69c42499cdfd038f9ac17e2e5543",
                "image": "",
                "source": "Fintel",
                "related": "SYK",
                "summary": "",
                "category": "company",
                "datetime": 1783645922,
                "headline": "BMO Capital Initiates Coverage of Stryker (SYK) with Outperform Recommendation"
              },
              {
                "id": 140854814,
                "url": "https://finnhub.io/api/news?id=11054f196b0e32b5c2809d2d7a6f50cab93df0a950a9feb5bb887db5b936089a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) has been removed from multiple Russell growth indices following the latest rebalancing. The company recently faced a cyberattack that disrupted certain operations. Despite the index exits and cyber incident, some active investors have shown renewed interest in the stock. These shifts may influence trading volumes and how both passive and active funds approach NYSE:SYK. Stryker is a large medical technology company focused on surgical equipment, orthopedics and related...",
                "category": "company",
                "datetime": 1783624224,
                "headline": "Stryker (SYK) Stock Loses Russell Growth Slots As Active Investors Step In"
              },
              {
                "id": 140856698,
                "url": "https://finnhub.io/api/news?id=a0e9022521464a80a09aceb92a9e4ff94ca4114c58c5fbd73d33dc98e37a81ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker is set to post its second-quarter results later this month, and analysts project a double-digit earnings growth.",
                "category": "company",
                "datetime": 1783614433,
                "headline": "Stryker's Quarterly Earnings Preview: What You Need to Know"
              },
              {
                "id": 140853728,
                "url": "https://finnhub.io/api/news?id=afb7bb7649d73fdfc58e4a1c34838d3a219a2539822045c42434a80349996b22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here. The global equity market continued its rally in May, driven by accelerating AI infrastructure spending and a stronger-than-expected earnings season. The Fund (Platform Class) returned 2.1%, underperforming the MSCI World ex-Australia Index’s 4.5% […]",
                "category": "company",
                "datetime": 1783613050,
                "headline": "Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance"
              },
              {
                "id": 140852295,
                "url": "https://finnhub.io/api/news?id=33fcda0f34cf71ba33bf1f5fd26dd4a8a1bface677ea2b2eba3a0ad455a486ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The orthopedic surgical robots market presents growth opportunities in AI integration, digital workflows, and minimally invasive procedures. Key areas include knee, hip, spine, and shoulder robotics, with significant regional potential in Asia-Pacific and North America. Focus areas include innovation, ESG, and training. Orthopedic Surgical Robots Market Orthopedic Surgical Robots Market Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The \"Global Orthopedic Surgical Robots Market\" has been added to Res",
                "category": "company",
                "datetime": 1783608240,
                "headline": "Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic"
              },
              {
                "id": 140852127,
                "url": "https://finnhub.io/api/news?id=3dc0ae22f59ecc076a1a15b91bdc68fa65b5f68b674058d014aa38fddece5920",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "If you hold shares in this medical device maker, you are already carrying the full weight of a sizable potential swing that the market is pricing for the year ahead.",
                "category": "company",
                "datetime": 1783604422,
                "headline": "The Wide Chasm Priced Into Boston Scientific Stock"
              },
              {
                "id": 140850835,
                "url": "https://finnhub.io/api/news?id=9966738aa03e2c1d7bf64189594dd665e4ed1896a9b982f1abb0e878f0e60f2b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "The options market has priced a sizable range of outcomes for the surgical robotics leader, and if you hold the shares, you are already carrying that full exposure.",
                "category": "company",
                "datetime": 1783603762,
                "headline": "Just How Much Risk Is Built Into ISRG Stock?"
              },
              {
                "id": 140862585,
                "url": "https://finnhub.io/api/news?id=9df177a926fa1613790508f8a644ff4e09abe2c1402fb138291157d67a54c1ab",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "BMO Capital   initiates coverage on Stryker (NYSE:SYK) with a Outperform rating and announces Price Target of $369.",
                "category": "company",
                "datetime": 1783592223,
                "headline": "BMO Capital Initiates Coverage On Stryker with Outperform Rating, Announces Price Target of $369"
              },
              {
                "id": 140850500,
                "url": "https://finnhub.io/api/news?id=abd5251e75e6785b9c62af971b1d6f692745a5486eed4c6d763d18f9e5bce35f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2248458314/image_2248458314.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SYK",
                "summary": "Stryker (SYK) buy rating after a rare Q1 miss from a temporary cyber disruption. Full-year guidance holds; demand strong.",
                "category": "company",
                "datetime": 1783588719,
                "headline": "Stryker: The Market Is Overreacting To One Disrupted Quarter"
              },
              {
                "id": 140844394,
                "url": "https://finnhub.io/api/news?id=ab294aeeedf3bdd2dc056a6141333f005547f7b51c858f341bb42fee42682199",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Rising use of automation in healthcare is reshaping robotics ETFs as med-tech innovators gain prominence.",
                "category": "company",
                "datetime": 1783533840,
                "headline": "Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs"
              },
              {
                "id": 140843377,
                "url": "https://finnhub.io/api/news?id=0c81e90fd0177693e04c6f597f3094721aad21cf484f4f5e2f07a9365658f254",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "If you hold shares in this surgical robotics leader, you are already carrying a sizable two-sided risk, whether you trade options or not.",
                "category": "company",
                "datetime": 1783528899,
                "headline": "Just How Wide Is The Path Ahead For Intuitive Surgical Stock?"
              },
              {
                "id": 140843499,
                "url": "https://finnhub.io/api/news?id=34d6969d4b2f1003b268bcd94b1089a6f9c61146cfa33106e1f253c389d29e9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "ICUI vs. SYK: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1783525203,
                "headline": "ICUI vs. SYK: Which Stock Should Value Investors Buy Now?"
              },
              {
                "id": 140839793,
                "url": "https://finnhub.io/api/news?id=303ee684ee433beba364a488812c644cbdf27564c78a5b59a237e3643f317e29",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172700619/image_2172700619.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SYK",
                "summary": "Stryker stock looks undervalued with a 13% discount to fair value, a strong EPS growth outlook, and dividend potential. Click for more on SYK stock.",
                "category": "company",
                "datetime": 1783497600,
                "headline": "Stryker: Medtech On Sale, Benefiting From Industry Growth"
              },
              {
                "id": 140833104,
                "url": "https://finnhub.io/api/news?id=f73d9bb5aecbe9b69580b1a7d34036b80a10531a82d3d18ec22b3063bbc2320c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.",
                "category": "company",
                "datetime": 1783441260,
                "headline": "How Big Is the Appendectomy Opportunity for ISRG's Robotic Expansion?"
              },
              {
                "id": 140831587,
                "url": "https://finnhub.io/api/news?id=9d4adf0658bcfc2f9d524c005dd79c6afe5127eb5c50b2e91137e17ec21f9ab1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Delray Beach, FL, July 07, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global orthopedic devices market will grow from USD 51.61 billion in 2024 to USD 68.51 billion by 2030, at a CAGR of 4.8% during the forecast period. Market growth is fueled by the rising prevalence of musculoskeletal disorders, increasing geriatric population, growing demand for minimally invasive orthopedic procedures, and continuous technological advancements including robotic-assisted surgeries and smart orth",
                "category": "company",
                "datetime": 1783435500,
                "headline": "Orthopedic Devices Market to Grow from USD 51.61 Billion in 2024 to USD 68.51 Billion by 2030, at a CAGR of 4.8% - MarketsandMarkets™"
              },
              {
                "id": 140830065,
                "url": "https://finnhub.io/api/news?id=3c61c162eeb4a4ff55bbbf7eb416d76bd56a1411992abae065eed559761e61eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.",
                "category": "company",
                "datetime": 1783430548,
                "headline": "How To Target A 10% Yield While Catching The BSX Stock Knife?"
              },
              {
                "id": 140821047,
                "url": "https://finnhub.io/api/news?id=2912828987debfe482d154cb8869250ceca30533455825d752a5f8b801edaad6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.",
                "category": "company",
                "datetime": 1783351875,
                "headline": "Intuitive Surgical Stock Looks Weighed Down. Its After-Hours Growth Says Otherwise."
              },
              {
                "id": 140822462,
                "url": "https://finnhub.io/api/news?id=fb503b298eddbe55fa669632c0bf8202960ac03b9180070af394c3342a8ad8b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "JNJ's Q2 MedTech results will test whether cardiovascular, surgery and vision strength can offset ongoing China VBP headwinds and sustain growth.",
                "category": "company",
                "datetime": 1783349880,
                "headline": "J&J's MedTech Segment Eyes Another Strong Quarter in Q2"
              },
              {
                "id": 140825068,
                "url": "https://finnhub.io/api/news?id=3f55e9cbd2d456f75646822ef44c175b5e6878f63987e49b585dc6265c1077e5",
                "image": "",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $355 to $350.",
                "category": "company",
                "datetime": 1783342719,
                "headline": "Evercore ISI Group Maintains Outperform on Stryker, Lowers Price Target to $350"
              },
              {
                "id": 140818838,
                "url": "https://finnhub.io/api/news?id=4a9dad0cdd3d6382d067ef903737da740abba78f9122b0856f78660880f6c0b9",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "When searching for dividend stocks, avoid high-yield traps. Stryker (SYK) offers a sustainable 1.08% yield with strong 7.89% annual growth, solid profitability, and a healthy payout ratio.",
                "category": "company",
                "datetime": 1783335033,
                "headline": "Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income"
              },
              {
                "id": 140821122,
                "url": "https://finnhub.io/api/news?id=bc1a01e4a3153aeaa577fecd21bc76829a5c301b0d3227ab5365e40dcf8bb30d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.",
                "category": "company",
                "datetime": 1783332000,
                "headline": "Top 10 medtech deals in the first half of 2026"
              },
              {
                "id": 140807143,
                "url": "https://finnhub.io/api/news?id=a602ea2eae629270a77afc0aa10501bc1cda26cc95a9263acdfdcd32bc4d4450",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker Corp (NYSE:SYK) is one of the best robotics stocks to buy. On June 12, BTIG analyst Ryan Zimmerman reiterated a Buy rating and a $379 price target on Stryker Corp (NYSE:SYK). The price target represents significant upside potential as the stock is trading at about $316 a share. The bullish stance comes on the […]",
                "category": "company",
                "datetime": 1783172856,
                "headline": "Is Stryker Corp. (SYK) The Best Robotic Stock to Buy?"
              },
              {
                "id": 140794039,
                "url": "https://finnhub.io/api/news?id=8831e57c447685f7d89edb07b4c239f2b6fa697dd0711d22279e85d63efc7d36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "While a guidance cut has reset expectations, several core Boston Scientific franchises are accelerating. The Neuromodulation and Interventional Oncology businesses both posted organic sales growth of 15% last quarter. This internal momentum in high-value categories contrasts sharply with the new, more cautious company-wide outlook.",
                "category": "company",
                "datetime": 1783013922,
                "headline": "What Could Push BSX Stock Higher From Here?"
              },
              {
                "id": 140789827,
                "url": "https://finnhub.io/api/news?id=0fb14c188d8c67b97d0d1a1e96422d17565cd40e09bbf6a93265a6ffd02b1349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
                "category": "company",
                "datetime": 1782990024,
                "headline": "1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges"
              },
              {
                "id": 140788777,
                "url": "https://finnhub.io/api/news?id=9a39c2abc725d4de8ebd5d279d74ed883a91ec0a741e35cb36275b53cba2213e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215945492/image_2215945492.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SYK",
                "summary": "Stryker looks undervalued after a cyber incident, with 32 years of dividend hikes, strong cash flow and M&A growth. Learn more on SYK stock here.",
                "category": "company",
                "datetime": 1782969939,
                "headline": "Stryker: The Reshaped Product Portfolio Will Drive Growth"
              },
              {
                "id": 140780530,
                "url": "https://finnhub.io/api/news?id=d0fe8c0ba178e00be1e131acac41a495e6ce7890f6beb2590347eb46bd0642ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results. Stryker absorbed a March 11 cyberattack and heavy restructuring charges while defending its joint replacement franchise. Intuitive posted another crisp beat on the back of da Vinci 5 adoption. Two medtech giants, two very different quarters. A Cyber ... Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation",
                "category": "company",
                "datetime": 1782918871,
                "headline": "Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation"
              },
              {
                "id": 140779549,
                "url": "https://finnhub.io/api/news?id=11dd89d9640d405a6f6db7f49162e5b0b4036c8385e032b06056d3e009346d25",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter",
                "category": "company",
                "datetime": 1782907200,
                "headline": "Stryker to announce second quarter 2026 financial results"
              },
              {
                "id": 140774276,
                "url": "https://finnhub.io/api/news?id=1607dff3285f4bc45cf8ebe7c9ed22e9600f5e1d933634515c11aa2327149b00",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1782846300,
                "headline": "Top S&P500 movers in Tuesday's session"
              },
              {
                "id": 140780221,
                "url": "https://finnhub.io/api/news?id=e5084c428cf75b8d527a4321c3cd00c93238e849646ed673fd49736eae9ec65c",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "SYK",
                "summary": "Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.17% on an annualized basis producing an average annual return of 10.45%. Currently, Stryker has a market capitalization of $120.58 billion.",
                "category": "company",
                "datetime": 1782839729,
                "headline": "If You Invested $1000 In Stryker Stock 20 Years Ago, You Would Have This Much Today"
              },
              {
                "id": 140773254,
                "url": "https://finnhub.io/api/news?id=45ffab8e93f60bba9fc6207e83277e70f09ef21e40612c43f8cf49acb4ed4d4b",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "SYK",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1782837301,
                "headline": "Which S&P500 stocks are moving on Tuesday?"
              },
              {
                "id": 140772070,
                "url": "https://finnhub.io/api/news?id=17bd4c797ef7cc747361285011496ed1a3e9002a5368b53bcc55e268c39f4406",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "If you are wondering whether Stryker stock is offering fair value or a potential opportunity right now, the key is understanding what the current price is actually reflecting. The stock last closed at US$330.52, with returns of 8.5% over the past week and 8.3% over the past month, while the return year to date is down 5.1% and the return over the past year is down 15.6%. Recent headlines around Stryker have kept the stock on many investors' watchlists, as the company continues to sit at the...",
                "category": "company",
                "datetime": 1782821256,
                "headline": "Stryker (SYK) Stock Weighs DCF Upside Against High P/E After Recent Price Rebound"
              },
              {
                "id": 140771630,
                "url": "https://finnhub.io/api/news?id=53e8a8231d3d21ce976866bd5f78c9ea51437b2410288a7e04d3527dd6887dba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "On 27 June 2026, Stryker Corporation was removed from multiple Russell growth indexes, including the Russell 1000 Growth, Russell 3000 Growth, Russell Top 200 Growth, and Russell 3000E Growth benchmarks. This broad index removal matters because it can trigger compulsory selling by index-tracking funds, reshaping who owns Stryker shares and how they trade. Next, we’ll examine how Stryker’s removal from several Russell growth benchmarks could influence its existing investment narrative and...",
                "category": "company",
                "datetime": 1782814041,
                "headline": "Stryker (SYK) Is Up 8.5% After Broad Russell Growth Index Removal Reshapes Its Shareholder Base"
              },
              {
                "id": 140765525,
                "url": "https://finnhub.io/api/news?id=27063d3a286c41bc95f3fbd723af7d076927548982493424e81d400666ffb8d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Is SYK a good stock to buy? We came across a bullish thesis on Stryker Corporation on MaxDividends’s Substack by Serhio MaxDividends. In this article, we will summarize the bulls’ thesis on SYK. Stryker Corporation’s share was trading at $313.68 as of June 24th. SYK’s trailing and forward P/E were 36.31 and 20.92 respectively according to Yahoo […]",
                "category": "company",
                "datetime": 1782761641,
                "headline": "Is Stryker Corporation (SYK) A Good Stock To Buy Now?"
              },
              {
                "id": 140760902,
                "url": "https://finnhub.io/api/news?id=66e0acb534e9a1dd7c85fafcb27df8a2e8fd35dcf3135e76cfb2189a79f0a166",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
                "category": "company",
                "datetime": 1782726540,
                "headline": "Stryker (SYK) Moves 5.3% Higher: Will This Strength Last?"
              },
              {
                "id": 140756685,
                "url": "https://finnhub.io/api/news?id=b035ec48a96b8e72493d5c19bc3a8486393fbc86e5d0fa25b90ff18b5b10be1d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SYK",
                "summary": "Stryker Corporation (NYSE:SYK) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds. On June 2, Stryker Corporation (NYSE:SYK) announced the launch of TPX HD. It is a small bone power tool designed for demanding orthopaedic procedures, including total joint revisions, minimally invasive surgery, and oral maxillofacial procedures. Mike Carlin, […]",
                "category": "company",
                "datetime": 1782676687,
                "headline": "Stryker Corporation (SYK) launches TPX HD® Power Tool"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 73,
            "discarded_article_count": 57
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.9,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 3,
          "vcpPoints": 1.5,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日4日)；站上MA50；收盤突破20日高位；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 2600566.6666666665,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2383730,
              "avg_vol_20": 2617210,
              "avg_vol_30": 2600566.6666666665,
              "range_pct_10": 0.08796101110533391,
              "range_pct_20": 0.08796101110533391,
              "range_pct_30": 0.10975824403867211,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.9166194547342247,
              "dist_to_20d_high": -0.0017551688756557006,
              "down_shrink_days": 4,
              "breakout_level_20d": 336.14999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.8014068726750203
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.037328592900416,
              "turnoverUsdM": 553.98274344865,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.SYK",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 316.2842,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 6.1,
            "take_profit_price": 360.0596,
            "target_multiplier": 1.9,
            "technical_strength": 1.8,
            "take_profit_percent": 6.9
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.074657185800832,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.SYK",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 10.2279,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.04
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 132.98
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0402
    },
    "kdj": {
      "d": 51.46,
      "j": 91.7,
      "k": 64.87,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 51.34
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 14171135,
      "recentSlope": 389733.5,
      "previousSlope": -231480
    },
    "rsi": 53.59,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 10,
      "trend": "上升",
      "value": 306.53,
      "position": "SAR由上轉下+趨勢強",
      "distancePct": 8.97,
      "previousTrend": "下降"
    },
    "ma50": 314.6064,
    "macd": {
      "macd": 2.980150448666791,
      "trend": "強烈看漲",
      "signal": 2.612430042365485,
      "histogram": 0.36772040630130576
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 6,
      "value": 322.3014,
      "position": "連續1-2日>VWAP",
      "consecutiveAbove": 2
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.68,
      "score": 2,
      "avgVolume": 2424077,
      "currentVolume": 1645135
    },
    "derived": {
      "ma20": 323.1225,
      "ma50": 314.6064,
      "prevClose": 330.25,
      "avgVolume10": 2326474,
      "avgVolume20": 2424077,
      "changePercent": 1.97,
      "avgVolumeForScore": 2424077
    },
    "ma_cross": {
      "ma20": 323.1225,
      "ma50": 314.6064,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 322.921,
      "prevMa50": 313.9134,
      "spreadPct": 2.71,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 307.4998,
      "upper": 338.7452,
      "position": "上半部"
    },
    "rsi_short": 72.12,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.68
    }
  }
}

Raw metrics JSON

 
{
  "close": 336.74,
  "volume": 1645135,
  "changePercent": 1.97
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.